Blood Transfusion Diagnostics Market - Global Industry Analysis

Blood Transfusion Diagnostics Market By Product Type (Instruments, Kits & Reagents), By Application (Blood Grouping, Molecular Disease Screening), By End-user (Hospitals, Diagnostic Laboratories, Blood Banks), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 08-Jun-2022 Category: Medical Device Report Format : PDF Pages: 205 Report Code: ZMR-3408 Status : Published

Request For Customization Request Free Brochure Request Free Sample Buy Now

Description

Industry Prospective:

The global blood transfusion diagnostics market was worth around USD 4.5 billion in 2021 and is estimated to grow to about USD 7.2 billion by 2028, with a compound annual growth rate (CAGR) of approximately 7.5 percent over the forecast period. The report analyzes the blood transfusion diagnostics market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the blood transfusion diagnostics market.

Blood Transfusion Diagnostics Market: Overview

The term "blood transfusion diagnostics" refers to tests performed on blood and blood components prior to their transfusion to patients. To avoid adverse reactions or infection transmission, every blood unit should be screened for blood group type and diseases. It's an important aspect of transfusion therapy since it gives healthcare workers important information and ensures the compatibility of recipient and donor blood samples.

COVID-19 Impact:

The Covid-19 outbreak had a moderate impact on the global blood transfusion diagnostics market. The pandemic has caused a drop in voluntary blood donations and has impacted the global supply chain for medical devices. During the crisis, blood banks and hospitals faced a number of serious obstacles, including a scarcity of blood units, a shortage of staff, decreased donor inflow, and public fears regarding transfusion-transmitted COVID-19. On the other hand, the pandemic of COVID-19 has created new potential for the blood transfusion diagnostics sector. In the United States, a set of plasma transfusion trials are underway. The liquid medium is extracted from recovered participants and given to infected patients. Also, the market is expected to grow substantially during the forecast period.

Global Blood Transfusion Diagnostics Market

Blood Transfusion Diagnostics Market: Growth Drivers

Growing need for blood transfusion to foster the growth of the market

Blood transfusion demand is being driven by the growing prevalence of infectious and chronic diseases such as severe thrombocytopenia, sickle cell disease, liver disease, kidney disease, hemophilia, cancer, and anemia. According to WHO, anemia was shown to be prevalent in 29.9% of reproductive-age women globally, equating to nearly half a billion females aged 15 to 49. Non-pregnant females of reproductive age had a prevalence of 29.6%, while pregnant women had a prevalence of 36.5 %. In addition to this, the market is being driven by an increase in the number of delivery cases, surgeries, car accidents, and trauma, all of which have resulted in substantial transfusions. Transfusion-transmitted Infections (TTIs) are becoming more common, resulting in a significant demand for donor screening, thereby fueling the market growth.

Blood Transfusion Diagnostics Market: Restraints

High cost associated with the equipment and test to limit the market growth

For the long-term viability of health services that meet quality standards, it is critical to assess the cost and suitability of diagnosis & treatment approaches. Hospitals have evolved into socioeconomic institutions as medical technology has advanced, and they now account for a considerable portion of healthcare costs. The cost of allogeneic blood transfusion varies depending on the application in therapy expenditures. Purchase, treat transfusion-induced responses, monitor, dispose of it as medical waste, supply blood components to relevant clinics, test & preparation of the component suitable for transfusion, and submit all required information imposes an expensive burden. All such factors coupled with the high cost of kits & reagents may impede the growth of the global blood transfusion diagnostics market.

Blood Transfusion Diagnostics Market: Opportunities

Introduction of advanced diagnostics and kits to drive the market during the forecast period.

With the technological advancements in the healthcare domain, there is introduction of advanced and reliable diagnostics as well as reagents & kits for blood transfusion. Players in the market are focusing on implementing technical breakthroughs in testing techniques. Plasma fractionation is an example of such technological advancement. These factors are estimated to open numerous opportunities for the growth of the market. Also, factors such as growing demand for molecular-based screening of diseases and launch as well as approval of advanced systems have the potential to boost the market during the forecast period.

Blood Transfusion Diagnostics Market: Challenges.

Lack of skilled professionals poses a challenge for the market

The prime challenge for the blood transfusion diagnostics market is the lack of skilled professionals to operate advanced equipment & kits used for tests and screening of the blood. In addition to this, strict regulatory bodies and unawareness of blood donations in underdeveloped countries are also some of the factors that pose a challenge to the growth of the market.

Blood Transfusion Diagnostics Market: Segmentation

The global blood transfusion diagnostics market is divided based on product type, application, end-user, and region. On the basis of product type, the global market is fragmented into kits & reagents and instruments. By application, the market is split into molecular disease screening and blood grouping. Based on the end-user segment, the market is classified into blood banks, diagnostic laboratories, and hospitals.

Report Scope:

Report Attribute	Details
Base Year	2020
Historic Years	2016 - 2020
Forecast Years	2021 - 2028
Segments Covered	By Product Type, By Application, and By End Use
Forecast Units	Value (USD Billion), and Volume (Units)
Quantitative Units	Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered	U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered	10 companies with scope for including additional 15 companies upon request
Report Coverage	Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope	Avail customized purchase options to meet your exact research needs.

Recent Developments

In April 2021, ORTHO VISION Max Swift and ORTHO VISION Swift analyzers were introduced by Ortho Clinical Diagnostics. These analyzers provide laboratory networks with increased processing power and enhanced data security.

Blood Transfusion Diagnostics Market: Regional Landscape

North America to dominate the global market during upcoming period

Among the regions, North America is estimated to hold the largest share in the global blood transfusion diagnostics market during the forecast period. The region's predominance is attributable to a well-established healthcare infrastructure, more public knowledge about blood donations, and better acceptance of the blood transfusion method. According to the National Centre for Biotechnology Information, over 15 million blood units are transfused in the United States each year, and about 85 million units are transfused globally. Due to the wide availability of CE-approved instrument assays for Nucleic Acid Test (NAT) and serological test-based procedures in European countries, the market in Europe is expected to develop at a considerable CAGR. The market in the Asia Pacific is anticipated to grow at a rapid rate during the forecast period.

Blood Transfusion Diagnostics Market: Competitive Landscape

Some of the predominant players that are operating in the global blood transfusion diagnostics market include F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Abbott, Ortho Clinical Diagnostics, Immucor, Inc., BIOKIT, Danaher, DiaSorin S.P.A., BAG Healthcare GmbH, and Quotient Limited, among others.

Global blood transfusion diagnostics market is segmented as follows:

By Product Type

Instruments
Kits & Reagents

By Application

Blood Grouping
Molecular Disease Screening

By End User

Hospitals
Diagnostic Laboratories
Blood Banks

By Region

North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa

Table Of Content

Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
  - 1.3.1 Market Research Type
  - 1.3.2 Market research methodology
Chapter 2. Executive Summary
- 2.1 Global Blood Transfusion Diagnostics Market, (2022 - 2028) (USD Billion)
- 2.2 Global Blood Transfusion Diagnostics Market : snapshot
Chapter 3. Global Blood Transfusion Diagnostics Market - Industry Analysis
- 3.1 Blood Transfusion Diagnostics Market: Market Dynamics
- 3.2 Market Drivers
  - 3.2.1 Growing need for blood transfusion to foster the growth of the market
- 3.3 Market Restraints
  - 3.3.1. High cost associated with the equipment and test to limit the market growth
- 3.4 Market Opportunities
  - 3.4.1. Introduction of advanced diagnostics and kits to drive the market during the forecast period.
- 3.5 Market Challenges
  - 3.5.1. Lack of skilled professionals poses a challenge for the market
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
  - 3.7.1 Market attractiveness analysis By Product Type
  - 3.7.2 Market attractiveness analysis By Application
  - 3.7.3 Market attractiveness analysis By End User
Chapter 4. Global Blood Transfusion Diagnostics Market- Competitive Landscape
- 4.1 Company market share analysis
  - 4.1.1 Global Blood Transfusion Diagnostics Market: company market share, 2021
- 4.2 Strategic development
  - 4.2.1 Acquisitions & mergers
  - 4.2.2 New Product launches
  - 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
  - 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
Chapter 5. Global Blood Transfusion Diagnostics Market - Product Type Analysis
- 5.1 Global Blood Transfusion Diagnostics Market overview: By Product Type
  - 5.1.1 Global Blood Transfusion Diagnostics Market share, By Product Type, 2021 and 2028
- 5.2 Instruments
  - 5.2.1 Global Blood Transfusion Diagnostics Market by Instruments, 2022 - 2028 (USD Billion)
- 5.3 Kits & Reagents
  - 5.3.1 Global Blood Transfusion Diagnostics Market by Kits & Reagents, 2022 - 2028 (USD Billion)
Chapter 6. Global Blood Transfusion Diagnostics Market - Application Analysis
- 6.1 Global Blood Transfusion Diagnostics Market overview: By Application
  - 6.1.1 Global Blood Transfusion Diagnostics Market share, By Application, 2021 and 2028
- 6.2 Blood Grouping
  - 6.2.1 Global Blood Transfusion Diagnostics Market by Blood Grouping, 2022 - 2028 (USD Billion)
- 6.3 Molecular Disease Screening
  - 6.3.1 Global Blood Transfusion Diagnostics Market by Molecular Disease Screening, 2022 - 2028 (USD Billion)
Chapter 7. Global Blood Transfusion Diagnostics Market - End User Analysis
- 7.1 Global Blood Transfusion Diagnostics Market overview: By End User
  - 7.1.1 Global Blood Transfusion Diagnostics Market share, By End User, 2021 and 2028
- 7.2 Hospitals
  - 7.2.1 Global Blood Transfusion Diagnostics Market by Hospitals, 2022 - 2028 (USD Billion)
- 7.3 Diagnostic Laboratories
  - 7.3.1 Global Blood Transfusion Diagnostics Market by Diagnostic Laboratories, 2022 - 2028 (USD Billion)
- 7.4 Blood Banks
  - 7.4.1 Global Blood Transfusion Diagnostics Market by Blood Banks, 2022 - 2028 (USD Billion)
Chapter 8. Blood Transfusion Diagnostics Market - Regional Analysis
- 8.1 Global Blood Transfusion Diagnostics Market Regional Overview
- 8.2 Global Blood Transfusion Diagnostics Market Share, by Region, 2021 & 2028 (USD Billion)
- 8.3. North America
  - 8.3.1 North America Blood Transfusion Diagnostics Market, 2022 - 2028 (USD Billion)
    - 8.3.1.1 North America Blood Transfusion Diagnostics Market, by Country, 2022 - 2028 (USD Billion)
- 8.4 North America Blood Transfusion Diagnostics Market, by Product Type, 2022 - 2028
  - 8.4.1 North America Blood Transfusion Diagnostics Market, by Product Type, 2022 - 2028 (USD Billion)
- 8.5 North America Blood Transfusion Diagnostics Market, by Application, 2022 - 2028
  - 8.5.1 North America Blood Transfusion Diagnostics Market, by Application, 2022 - 2028 (USD Billion)
- 8.6 North America Blood Transfusion Diagnostics Market, by End User, 2022 - 2028
  - 8.6.1 North America Blood Transfusion Diagnostics Market, by End User, 2022 - 2028 (USD Billion)
- 8.4. Europe
  - 8.4.2 Europe Blood Transfusion Diagnostics Market, 2022 - 2028 (USD Billion)
    - 8.4.2.1 Europe Blood Transfusion Diagnostics Market, by Country, 2022 - 2028 (USD Billion)
- 8.4 Europe Blood Transfusion Diagnostics Market, by Product Type, 2022 - 2028
  - 8.4.1 Europe Blood Transfusion Diagnostics Market, by Product Type, 2022 - 2028 (USD Billion)
- 8.5 Europe Blood Transfusion Diagnostics Market, by Application, 2022 - 2028
  - 8.5.1 Europe Blood Transfusion Diagnostics Market, by Application, 2022 - 2028 (USD Billion)
- 8.6 Europe Blood Transfusion Diagnostics Market, by End User, 2022 - 2028
  - 8.6.1 Europe Blood Transfusion Diagnostics Market, by End User, 2022 - 2028 (USD Billion)
- 8.5. Asia Pacific
  - 8.5.3 Asia Pacific Blood Transfusion Diagnostics Market, 2022 - 2028 (USD Billion)
    - 8.5.3.1 Asia Pacific Blood Transfusion Diagnostics Market, by Country, 2022 - 2028 (USD Billion)
- 8.4 Asia Pacific Blood Transfusion Diagnostics Market, by Product Type, 2022 - 2028
  - 8.4.1 Asia Pacific Blood Transfusion Diagnostics Market, by Product Type, 2022 - 2028 (USD Billion)
- 8.5 Asia Pacific Blood Transfusion Diagnostics Market, by Application, 2022 - 2028
  - 8.5.1 Asia Pacific Blood Transfusion Diagnostics Market, by Application, 2022 - 2028 (USD Billion)
- 8.6 Asia Pacific Blood Transfusion Diagnostics Market, by End User, 2022 - 2028
  - 8.6.1 Asia Pacific Blood Transfusion Diagnostics Market, by End User, 2022 - 2028 (USD Billion)
- 8.6. Latin America
  - 8.6.4 Latin America Blood Transfusion Diagnostics Market, 2022 - 2028 (USD Billion)
    - 8.6.4.1 Latin America Blood Transfusion Diagnostics Market, by Country, 2022 - 2028 (USD Billion)
- 8.4 Latin America Blood Transfusion Diagnostics Market, by Product Type, 2022 - 2028
  - 8.4.1 Latin America Blood Transfusion Diagnostics Market, by Product Type, 2022 - 2028 (USD Billion)
- 8.5 Latin America Blood Transfusion Diagnostics Market, by Application, 2022 - 2028
  - 8.5.1 Latin America Blood Transfusion Diagnostics Market, by Application, 2022 - 2028 (USD Billion)
- 8.6 Latin America Blood Transfusion Diagnostics Market, by End User, 2022 - 2028
  - 8.6.1 Latin America Blood Transfusion Diagnostics Market, by End User, 2022 - 2028 (USD Billion)
- 8.7. The Middle-East and Africa
  - 8.7.5 The Middle-East and Africa Blood Transfusion Diagnostics Market, 2022 - 2028 (USD Billion)
    - 8.7.5.1 The Middle-East and Africa Blood Transfusion Diagnostics Market, by Country, 2022 - 2028 (USD Billion)
- 8.4 The Middle-East and Africa Blood Transfusion Diagnostics Market, by Product Type, 2022 - 2028
  - 8.4.1 The Middle-East and Africa Blood Transfusion Diagnostics Market, by Product Type, 2022 - 2028 (USD Billion)
- 8.5 The Middle-East and Africa Blood Transfusion Diagnostics Market, by Application, 2022 - 2028
  - 8.5.1 The Middle-East and Africa Blood Transfusion Diagnostics Market, by Application, 2022 - 2028 (USD Billion)
- 8.6 The Middle-East and Africa Blood Transfusion Diagnostics Market, by End User, 2022 - 2028
  - 8.6.1 The Middle-East and Africa Blood Transfusion Diagnostics Market, by End User, 2022 - 2028 (USD Billion)
Chapter 9. Company Profiles
- 9.1 F. Hoffmann-La Roche AG
  - 9.1.1 Overview
  - 9.1.2 Financials
  - 9.1.3 Product Portfolio
  - 9.1.4 Business Strategy
  - 9.1.5 Recent Developments
- 9.2 Bio-Rad Laboratories
  - 9.2.1 Overview
  - 9.2.2 Financials
  - 9.2.3 Product Portfolio
  - 9.2.4 Business Strategy
  - 9.2.5 Recent Developments
- 9.3 Abbott
  - 9.3.1 Overview
  - 9.3.2 Financials
  - 9.3.3 Product Portfolio
  - 9.3.4 Business Strategy
  - 9.3.5 Recent Developments
- 9.4 Ortho Clinical Diagnostics
  - 9.4.1 Overview
  - 9.4.2 Financials
  - 9.4.3 Product Portfolio
  - 9.4.4 Business Strategy
  - 9.4.5 Recent Developments
- 9.5 Immucor Inc.
  - 9.5.1 Overview
  - 9.5.2 Financials
  - 9.5.3 Product Portfolio
  - 9.5.4 Business Strategy
  - 9.5.5 Recent Developments
- 9.6 BIOKIT
  - 9.6.1 Overview
  - 9.6.2 Financials
  - 9.6.3 Product Portfolio
  - 9.6.4 Business Strategy
  - 9.6.5 Recent Developments
- 9.7 Danaher
  - 9.7.1 Overview
  - 9.7.2 Financials
  - 9.7.3 Product Portfolio
  - 9.7.4 Business Strategy
  - 9.7.5 Recent Developments
- 9.8 DiaSorin S.P.A.
  - 9.8.1 Overview
  - 9.8.2 Financials
  - 9.8.3 Product Portfolio
  - 9.8.4 Business Strategy
  - 9.8.5 Recent Developments
- 9.9 BAG Healthcare GmbH
  - 9.9.1 Overview
  - 9.9.2 Financials
  - 9.9.3 Product Portfolio
  - 9.9.4 Business Strategy
  - 9.9.5 Recent Developments
- 9.10 Quotient Limited
  - 9.10.1 Overview
  - 9.10.2 Financials
  - 9.10.3 Product Portfolio
  - 9.10.4 Business Strategy
  - 9.10.5 Recent Developments

Table Of Figures

1. Market research Type
2. Market research methodology
3. Global Blood Transfusion Diagnostics Market, 2022 - 2028 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Blood Transfusion Diagnostics Market attractiveness, By Product Type
6. Global Blood Transfusion Diagnostics Market attractiveness, By Application
7. Global Blood Transfusion Diagnostics Market attractiveness, By End User
8. Global Blood Transfusion Diagnostics Market share by Product Type, 2022 and 2028 (USD Billion)
9. Global Blood Transfusion Diagnostics Market by Instruments, 2022 - 2028 (USD Billion)
10. Global Blood Transfusion Diagnostics Market by Kits & Reagents, 2022 - 2028 (USD Billion)
11. Global Blood Transfusion Diagnostics Market share by Application, 2022 and 2028 (USD Billion)
12. Global Blood Transfusion Diagnostics Market by Blood Grouping, 2022 - 2028 (USD Billion)
13. Global Blood Transfusion Diagnostics Market by Molecular Disease Screening, 2022 - 2028 (USD Billion)
14. Global Blood Transfusion Diagnostics Market share by End User, 2022 and 2028 (USD Billion)
15. Global Blood Transfusion Diagnostics Market by Hospitals, 2022 - 2028 (USD Billion)
16. Global Blood Transfusion Diagnostics Market by Diagnostic Laboratories, 2022 - 2028 (USD Billion)
17. Global Blood Transfusion Diagnostics Market by Blood Banks, 2022 - 2028 (USD Billion)
18. Global Blood Transfusion Diagnostics Market share, by Region, 2022 and 2028
19. North America Blood Transfusion Diagnostics Market, 2022 - 2028 (USD Billion)
20. Europe Blood Transfusion Diagnostics Market, 2022 - 2028 (USD Billion)
21. Asia Pacific Blood Transfusion Diagnostics Market, 2022 - 2028 (USD Billion)
22. Latin America Blood Transfusion Diagnostics Market, 2022 - 2028 (USD Billion)
23. The Middle-East and Africa Blood Transfusion Diagnostics Market, 2022 - 2028 (USD Billion)

Table Of Tables

1. Global Blood Transfusion Diagnostics Market: Snapshot
2. Drivers of the Blood Transfusion Diagnostics Market: impact analysis
3. North America Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
4. North America Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
5. North America Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
6. U.S. Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
7. U.S. Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
8. U.S. Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
9. Canada Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
10. Canada Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
11. Canada Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
12. Europe Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
13. Europe Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
14. Europe Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
15. Germany Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
16. Germany Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
17. Germany Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
18. France Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
19. France Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
20. France Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
21. U.K. Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
22. U.K. Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
23. U.K. Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
24. Italy Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
25. Italy Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
26. Italy Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
27. Spain Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
28. Spain Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
29. Spain Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
30. Rest of Europe Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
31. Rest of Europe Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
32. Rest of Europe Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
33. Asia Pacific Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
34. Asia Pacific Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
35. Asia Pacific Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
36. China Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
37. China Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
38. China Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
39. Japan Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
40. Japan Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
41. Japan Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
42. India Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
43. India Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
44. India Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
45. South Korea Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
46. South Korea Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
47. South Korea Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
48. South-East Asia Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
49. South-East Asia Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
50. South-East Asia Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
51. Rest of Asia Pacific Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
52. Rest of Asia Pacific Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
53. Rest of Asia Pacific Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
54. Latin America Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
55. Latin America Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
56. Latin America Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
57. Brazil Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
58. Brazil Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
59. Brazil Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
60. Mexico Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
61. Mexico Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
62. Mexico Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
63. Rest of Latin America Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
64. Rest of Latin America Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
65. Rest of Latin America Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
66. The Middle-East and Africa Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
67. The Middle-East and Africa Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
68. The Middle-East and Africa Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
69. GCC Countries Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
70. GCC Countries Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
71. GCC Countries Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
72. South Africa Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
73. South Africa Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
74. South Africa Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)
75. Rest of Middle-East Africa Blood Transfusion Diagnostics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
76. Rest of Middle-East Africa Blood Transfusion Diagnostics Market revenue, By Application, 2022 - 2028 (USD Billion)
77. Rest of Middle-East Africa Blood Transfusion Diagnostics Market revenue, By End User, 2022 - 2028 (USD Billion)

Methodology

Free Analysis

Blood transfusion is a process of receiving blood or blood products from one person to another. Blood transfusions are used for various medical conditions such as loss of blood or any other components of the blood. Blood transfusion diagnostics play an important role in blood transfusion in order to avoid infection to both the receiver and donor. In the past decade, molecular diagnostics has grown into a multibillion-dollar industry thanks to the major advancements in biological chemistries and instrumentation. Robust diagnostic techniques are being adopted, allowing the ability to quantitate the data using real-time PCR and other techniques. Hospitals and diagnostic laboratories are widely using molecular diagnostic techniques in blood transfusion testing and diagnosis. The tenfold growth in demand for diagnostic products and accessories from several end-users in the blood transfusion industry is augmenting the growth of blood transfusion diagnostic market. However, low blood donation rate and stringent regulations related to safe blood transfusion are a few hindrances faced by the global blood transfusion diagnostics market. On the other hand, rapid technological advancement and automation in blood processing equipment, increasing adoption of blood transfusion diagnostics in developing countries, and increasing government awareness programs are expected to offer the future prospects in the forecast period.

On the basis of product type, global blood transfusion diagnostics market is divided into kits and reagents, filtration systems, services, and others. Among these instruments and kits segment was the highest revenue grosser in 2016. Different kind of diagnostics kits and instruments are used in blood transfusion diagnosis operation. The increasing demand for instruments and kits in hospitals and diagnostic labs are expected to poise the growth of kits and reagent segment in the coming years.

Blood-Transfusion-Diagnostics-Market

On the basis of application, the market is divided into blood grouping and disease screening. The blood grouping dominated the application segment and accounted for the largest share in 2017.

The end-user segment includes hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies. Blood banks are the major source of blood and other products for transfusion and offer quality blood diagnostic services prior to transfusion. Blood banks segment was the leading segment in end-users and held the dominant share in terms of revenue in 2017. The diagnostic laboratories and hospital segments are expected to grow at the highest rate during the forecast period.

Based on the geography, the global blood transfusion diagnostics market is divided into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to remain the dominant region over the forecast period. Europe was the second largest market followed by the Asia Pacific. Asia Pacific was the fastest growing market with the highest CAGR during the forecast period. The Middle East and Africa and Latin America are expected to experience a moderate growth in the blood transfusion diagnostics market in the years to come.

Some of the major key players in blood transfusion diagnostics market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, DiaSorin S.p.A., BAG Health Care GmbH, Grifols, S.A., Bio-Rad Laboratories, Inc., Immucor, Inc., Quotient Limited, Hologic, Inc., and Ortho Clinical Diagnostics.

Choose License Type

Single User License

$4199.00 Multi User License

$5199.00 Enterprise Access License

$7199.00

Request the coronavirus impact analysis across industries and markets

Request impact analysis
on this market

RelatedNews

FrequentlyAsked Questions

Which key factors will influence blood transfusion diagnostics market growth over 2022-2028?

Blood transfusion demand is being driven by the growing prevalence of infectious and chronic diseases such as severe thrombocytopenia, sickle cell disease, liver disease, kidney disease, hemophilia, cancer, and anemia. In addition to this, the market is being driven by an increase in the number of delivery cases, surgeries, car accidents, and trauma, all of which have resulted in substantial transfusions. Transfusion-transmitted Infections (TTIs) are becoming more common, resulting in a significant demand for donor screening, thereby fueling the market growth.

What will be the value of the blood transfusion diagnostics market during 2022-2028?

According to the Zion Market Research report, the global blood transfusion diagnostics market was worth about 4.5 (USD billion) in 2021 and is predicted to grow to around 7.2 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 7.5 percent.